188 related articles for article (PubMed ID: 32238516)
21. Impact of biological rhythms on perception of illness and cognitive flexibility in bipolar patients in remission.
Kocakaya H; Yetkin S
Chronobiol Int; 2024 Mar; 41(3):406-416. PubMed ID: 38311973
[TBL] [Abstract][Full Text] [Related]
22. The Vietnamese Version of the Brief Illness Perception Questionnaire and the Beliefs about Medicines Questionnaire: Translation and Cross-cultural Adaptation.
Nguyen T; Cao HTK; Quach DN; Le KK; Au SX; Pham ST; Nguyen TH; Pham TT; Taxis K
Trop Med Int Health; 2019 Dec; 24(12):1465-1474. PubMed ID: 31599083
[TBL] [Abstract][Full Text] [Related]
23. Understanding illness perception in pulmonary tuberculosis patients: One step towards patient-centered care.
Min J; Chung C; Jung SS; Park HK; Lee SS; Lee KM
PLoS One; 2019; 14(6):e0218106. PubMed ID: 31188871
[TBL] [Abstract][Full Text] [Related]
24. Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis.
Hinojosa-Azaola A; Jiménez-González A; Alcocer-Castillejos N
Rheumatol Int; 2018 Apr; 38(4):631-640. PubMed ID: 29247347
[TBL] [Abstract][Full Text] [Related]
25. Perception of late effects among long-term survivors after haematopoietic stem cell transplantation: Descriptive analysis and validation of the Brief Illness Perception Questionnaire. A sub-study of the PROVIVO study.
Valenta S; De Geest S; Fierz K; Beckmann S; Halter J; Schanz U; Nair G; Kirsch M
Eur J Oncol Nurs; 2017 Apr; 27():17-27. PubMed ID: 28279392
[TBL] [Abstract][Full Text] [Related]
26. Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure.
El Miedany Y; El Gaafary M; Toth M; Palmer D; Ali A; Bahlas S; Mahran S; Hassan W; Abu-Zaid MH; Saber S; Elwakil W
Semin Arthritis Rheum; 2023 Dec; 63():152285. PubMed ID: 37944298
[TBL] [Abstract][Full Text] [Related]
27. Comparison of magnetic resonance angiography and
Quinn KA; Ahlman MA; Malayeri AA; Marko J; Civelek AC; Rosenblum JS; Bagheri AA; Merkel PA; Novakovich E; Grayson PC
Ann Rheum Dis; 2018 Aug; 77(8):1165-1171. PubMed ID: 29666047
[TBL] [Abstract][Full Text] [Related]
28. Patient Reported Outcomes in Large Vessel Vasculitides.
Robson J; Mackie S; Hill C
Curr Rheumatol Rep; 2021 Jan; 23(2):7. PubMed ID: 33511455
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
Furuta S; Cousins C; Chaudhry A; Jayne D
J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
[TBL] [Abstract][Full Text] [Related]
30. Vasculitis research: Current trends and future perspectives.
Misra DP; Naidu GSRSNK; Agarwal V; Sharma A
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():10-20. PubMed ID: 30168260
[TBL] [Abstract][Full Text] [Related]
31. Transcultural Adaptation and Validation of the Korean Version of the Brief Illness Perception Questionnaire for Patients with Pulmonary Tuberculosis.
Min J; Chang Y; Lee KM; Choe KH; An JY
J Glob Infect Dis; 2017; 9(3):113-116. PubMed ID: 28878523
[TBL] [Abstract][Full Text] [Related]
32. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
Front Immunol; 2019; 10():1135. PubMed ID: 31191526
[TBL] [Abstract][Full Text] [Related]
33. There's no sugar-coating psychological distress and illness perceptions in gestational diabetes mellitus: depression and anxiety are associated with negative illness perceptions.
Maguire PA; Cummings JA; Reay RE; Nolan CJ; Looi JCL
Australas Psychiatry; 2022 Feb; 30(1):64-69. PubMed ID: 34488491
[TBL] [Abstract][Full Text] [Related]
34. The Igbo Brief Illness Perceptions Questionnaire: A cross-cultural adaptation and validation study in Nigerian populations with chronic low back pain.
Igwesi-Chidobe CN; Sorinola IO; Godfrey EL
J Back Musculoskelet Rehabil; 2021; 34(3):399-411. PubMed ID: 33459695
[TBL] [Abstract][Full Text] [Related]
35. Causal attributions about disease onset and relapse in patients with systemic vasculitis.
Grayson PC; Amudala NA; McAlear CA; Leduc RL; Shereff D; Richesson R; Fraenkel L; Merkel PA
J Rheumatol; 2014 May; 41(5):923-30. PubMed ID: 24634202
[TBL] [Abstract][Full Text] [Related]
36. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
[TBL] [Abstract][Full Text] [Related]
37. [Large vessel vasculitis: giant cell arteritis and Takayasu arteritis].
Petitpierre S; Bart PA; Leimgruber A; Spertini F; Prior J; Spertini F
Rev Med Suisse; 2007 Apr; 3(108):1056-60, 1062-3. PubMed ID: 17552258
[TBL] [Abstract][Full Text] [Related]
38. [Perception in chronic illnesses: linguistic validation of the revised Illness Perception Questionnaire and the Brief Illness Perception Questionnaire for a Spanish population].
Pacheco-Huergo V; Viladrich C; Pujol-Ribera E; Cabezas-Peña C; Núñez M; Roura-Olmeda P; Amado-Guirado E; Núñez E; Del Val JL;
Aten Primaria; 2012 May; 44(5):280-7. PubMed ID: 21955598
[TBL] [Abstract][Full Text] [Related]
39. Vasculitis therapy refines vasculitis mechanistic classification.
Torp CK; Brüner M; Keller KK; Brouwer E; Hauge EM; McGonagle D; Kragstrup TW
Autoimmun Rev; 2021 Jun; 20(6):102829. PubMed ID: 33872767
[TBL] [Abstract][Full Text] [Related]
40. Development of outcome measures for giant cell arteritis for use in clinical trials and standard practice.
El Miedany Y; Elgaafary M; Toth M; Azim AA; Palmer D; Dolbear G; Abu-Zaid MH; Affam D; Hassan W; Elnady B; Tabra SA; Saber S
Clin Rheumatol; 2023 Nov; 42(11):3049-3057. PubMed ID: 37464103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
